.

Deeper Knowledge, Faster

  • Find suppliers and generic API sources
  • Predict branded drug patent expiration
  • Uncover prior art in expired and abandoned patents

► See Plans & Pricing

Upgrade to enjoy subscriber-only features like email alerts and data export. See the Plans and Pricing

Serving 500+ biopharmaceutical companies globally:

Citi
Merck
Queensland Health
Novartis
Argus Health
Boehringer Ingelheim
Farmers Insurance
Harvard Business School
Federal Trade Commission
Daiichi Sankyo

Generated: June 24, 2017

DrugPatentWatch Database Preview

Details for New Drug Application (NDA): 079096

« Back to Dashboard
NDA 079096 describes NAPROXEN SODIUM, which is a drug marketed by Hamilton Pharms, Glenmark Pharms Ltd, Actavis Labs Fl Inc, Purepac Pharm, Bionpharma Inc, Aurobindo Pharma Ltd, Ivax Sub Teva Pharms, Amneal Pharms Ny, Contract Pharmacal, Pliva, Teva, Able, Marksans Pharma, Sandoz, Granules India, Watson Labs, Roxane, Perrigo, Mylan, Dr Reddys Labs Inc, Lnk Intl Inc, Hikma, Sun Pharm Inds Ltd, Dr Reddys Labs Ltd, and Teva Pharms, and is included in thirty-four NDAs. It is available from one hundred and fifty-one suppliers. Additional details are available on the NAPROXEN SODIUM profile page.

The generic ingredient in NAPROXEN SODIUM is naproxen sodium; pseudoephedrine hydrochloride. There are forty-two drug master file entries for this compound. Thirteen suppliers are listed for this compound. Additional details are available on the naproxen sodium; pseudoephedrine hydrochloride profile page.

Summary for NDA: 079096

Tradename:
1
Applicant:
1
Ingredient:
1
Patents:1
Therapeutic Class:Analgesics
Anti-inflammatory Agents
Formulation / Manufacturing:see details

Pharmacology for NDA: 079096

Suppliers and Packaging for NDA: 079096

Tradename Generic Name Dosage NDA Application Type Supplier National Drug Code Package Code Package
NAPROXEN SODIUM
naproxen sodium
TABLET;ORAL 079096 ANDA Walgreens 0363-0168 0363-0168-01 1 BOTTLE, PLASTIC in 1 BOX (0363-0168-01) > 100 TABLET in 1 BOTTLE, PLASTIC
NAPROXEN SODIUM
naproxen sodium
TABLET;ORAL 079096 ANDA Walgreens 0363-0168 0363-0168-24 1 BOTTLE, PLASTIC in 1 BOX (0363-0168-24) > 24 TABLET in 1 BOTTLE, PLASTIC

Summary for product number 001

Active Rx/OTC/Discontinued:OTCDosage:TABLET;ORALStrengthEQ 200MG BASE
Approval Date:Dec 16, 2008TE:RLD:No


Complete Access Available with Subscription
« Back to Dashboard

For more information try a trial or see the database preview and plans and pricing

Serving 500+ biopharmaceutical companies globally:

Cerilliant
Express Scripts
Argus Health
Chubb
Cantor Fitzgerald
QuintilesIMS
Moodys
Boehringer Ingelheim
Federal Trade Commission
Dow

Drugs may be covered by multiple patents or regulatory protections. All trademarks and applicant names are the property of their respective owners or licensors. Although great care is taken in the proper and correct provision of this service, thinkBiotech LLC does not accept any responsibility for possible consequences of errors or omissions in the provided data. The data presented herein is for information purposes only. There is no warranty that the data contained herein is error free. thinkBiotech performs no independent verifification of facts as provided by public sources nor are attempts made to provide legal or investing advice. Any reliance on data provided herein is done solely at the discretion of the user. Users of this service are advised to seek professional advice and independent confirmation before considering acting on any of the provided information. thinkBiotech LLC reserves the right to amend, extend or withdraw any part or all of the offered service without notice.

Copyright 2002-2017 thinkBiotech LLC
ISSN: 2162-2639

Secure SSL Encrypted

Follow DrugPatentWatch:



Google
Twitter
Google Plus
botpot